NCT00003850View on ClinicalTrials.gov

Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

47

Participants

Timeline

Start Date

April 30, 1999

Primary Completion Date

June 30, 2003

Conditions

Head and Neck Cancer

Interventions

DRUG

thalidomide

Trial Locations (1)

77030

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH